Ramius Boosts Cypress Bid To $163M
A subsidiary of Ramius LLC announced Wednesday that it had sweetened an offer to acquire Cypress Bioscience Inc. to $4.25 per share, a move that values the reluctant target at about...To view the full article, register now.
Already a subscriber? Click here to view full article